InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Zordani Richard A. Jr., Director. Officer active across 1 company, notably Galectin Therapeutics INC. In total, 3 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €25k. History available since 14 January 2022. The latest transaction was filed on 4 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
5,000 shares@ US$1.6050.0051% mcap29.3% of flowCommon StockSEC:0001133416-22-000053:0
Ideal exit: 30 Dec 2022 (T+270)
5,000 shares@ US$2.02100.0% of flowCommon StockSEC:0001133416-22-000006
Ideal exit: 11 Oct 2022 (T+270)
5,000 shares@ US$2.020.0062% mcap35.3% of flowCommon StockSEC:0001133416-22-000006:0
Ideal exit: 11 Oct 2022 (T+270)
3 of 3 declarations
About Zordani Richard A. Jr.
Richard A. Zordani Jr. is a Director at GALECTIN THERAPEUTICS INC. In this role, he participates in the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is valuable in guiding the firm's research and development initiatives.
